Business Of Biotech cover image

002: The Biopharma Exit Strategy With Dr. Francois Nader

Business Of Biotech

00:00

The Benefits of an IPO

You talked quite a bit about the potential benefits of an IPO, some M&A strategy. When in your opinion does it make sense to stay private? I think some companies actually, and this is basically it. If you're lucky enough to have investors that have deep pockets who believe in the company and are willing to fund that long term,. staying public is much easier because frankly you don't have it to worry about the streets.

Play episode from 23:06
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app